---
title: "Citrus Aurantium Extract Synephrine Market Insights 2025, Global and Chinese Analysis and Forecast to 2032"
datePublished: Wed Nov 19 2025 14:14:39 GMT+0000 (Coordinated Universal Time)
cuid: cmi6338ww000202jp8vuy2inh
slug: citrus-aurantium-extract-synephrine-market-insights-2025-global-and-chinese-analysis-and-forecast-to-2032

---

# Citrus Aurantium Extract Synephrine Market Insights 2025, Global and Chinese Analysis and Forecast to 2032

<p><strong>MARKET INSIGHTS</strong></p><p>
</p><p>Global Citrus Aurantium Extract Synephrine market size was valued at USD 412.5 million in 2024. The market is projected to grow from USD 448.3 million in 2025 to USD 752.8 million by 2032, exhibiting a CAGR of 7.2% during the forecast period.</p><div><b>Download FREE Sample of this Report @ 
            <a href="https://www.24chemicalresearch.com/download-sample/168758/global-citrus-aurantium-extract-synephrine-market">
            https://www.24chemicalresearch.com/download-sample/168758/global-citrus-aurantium-extract-synephrine-market</a></b></div><br><p>
</p><p>Citrus Aurantium Extract Synephrine, commonly known as bitter orange extract, is a naturally occurring alkaloid compound found in citrus fruits. It serves as a key active ingredient in weight management supplements, sports nutrition products, and traditional medicines due to its stimulant and thermogenic properties. The extract is available in multiple grades including food, medical, and industrial variants, with applications spanning dietary supplements, pharmaceuticals, and functional foods.</p><p>
</p><p>The market growth is driven by rising consumer demand for natural weight loss solutions and increasing awareness about herbal supplements. While regulatory scrutiny remains a challenge in some regions, particularly regarding dosage limits, manufacturers are investing in clinical research to validate safety claims. The Asia-Pacific region, led by China's robust botanical extract industry, currently dominates production, though North American and European markets show the highest consumption rates for weight management applications.</p><p>
<strong>MARKET DYNAMICS</strong></p><p>
<strong>MARKET DRIVERS</strong></p><p>
</p><p style="text-align:center"><strong>Growing Demand for Weight Management Solutions to Propel Market Growth</strong></p><p>
</p><p>The global obesity epidemic continues to drive demand for effective weight management solutions, with <strong>Citrus Aurantium Extract Synephrine</strong> gaining significant traction as a natural alternative. Market analysis indicates that over 650 million adults worldwide were classified as obese in 2024, creating a substantial addressable market for thermogenic ingredients. Synephrine's mechanism of action, which stimulates Î²3-adrenergic receptors to enhance lipolysis and energy expenditure, aligns perfectly with consumer preference for science-backed natural weight loss aids. Clinical studies have demonstrated that synephrine supplementation can increase metabolic rate by 7-10% at typical dosage levels, making it particularly attractive in the sports nutrition and dietary supplement segments.</p><p>
</p><p style="text-align:center"><strong>Shift Toward Natural Ingredient Formulations in Dietary Supplements</strong></p><p>
</p><p>The dietary supplement industry is experiencing a paradigm shift toward <strong>plant-based</strong> and naturally-derived ingredients, with citrus aurantium extract positioned as a premium solution. Consumers increasingly distrust synthetic stimulants, creating opportunities for synephrine as a safer alternative to compounds like ephedrine. Market data reveals that 68% of supplement consumers now prioritize natural ingredient lists, particularly in weight management products. The adaptogenic properties of synephrine, combined with its established safety profile at recommended doses, have led to incorporation in over 1,200 supplement formulations globally as of 2024. This figure is projected to grow significantly as formulators seek compliant alternatives to controversial stimulants.</p><p>
</p><p style="text-align:center"><strong>Expansion of Functional Food and Beverage Applications</strong></p><p>
</p><p>Innovation in <strong>functional food formulations</strong> presents substantial growth potential for citrus aurantium extract. The global functional food market is projected to grow at a CAGR of 7.5% through 2032, with energy-boosting ingredients like synephrine gaining prominence. Food technologists are increasingly leveraging synephrine's thermogenic properties in products targeting metabolic health, with recent advancements in encapsulation technologies enabling stable incorporation into beverages and snack formats. The athletic performance segment particularly favors synephrine-enhanced products, with pre-workout formulations accounting for 42% of new product launches containing citrus extracts in 2024.</p><p>
<strong>MARKET RESTRAINTS</strong></p><p>
</p><p style="text-align:center"><strong>Regulatory Scrutiny and Safety Concerns Limit Market Penetration</strong></p><p>
</p><p>Despite growing demand, the <strong>Citrus Aurantium Extract Synephrine</strong> market faces significant regulatory headwinds across multiple jurisdictions. In 2024, approximately 15 national regulatory bodies maintained restrictions on synephrine concentrations in consumer products, citing potential cardiovascular risks at high doses. The European Food Safety Authority (EFSA) maintains a cautious stance, requiring extensive safety dossiers for product approvals. This regulatory uncertainty has constrained market growth in key European markets, where only 18% of weight management products contain significant synephrine levels compared to 39% in North America. Ongoing debates about appropriate dosage levels continue to create formulation challenges for manufacturers operating across multiple regions.</p><p>
</p><p style="text-align:center"><strong>Competition from Alternative Thermogenic Ingredients</strong></p><p>
</p><p>The market faces intensifying competition from <strong>emerging thermogenic compounds</strong> that offer similar benefits with fewer regulatory constraints. Green tea extract, capsaicin, and forskolin have gained significant market share, collectively accounting for 58% of thermogenic supplement sales in 2024. These alternatives benefit from stronger safety profiles and broader regulatory acceptance, appealing to risk-averse formulators. Furthermore, the development of novel stacked formulations combining multiple mild thermogenics has reduced reliance on single-ingredient solutions like synephrine. Market analysis suggests that while citrus aurantium remains a key player, its market share in the thermogenics category declined by approximately 3.2 percentage points between 2022 and 2024.</p><p>
</p><p style="text-align:center"><strong>Supply Chain Volatility for Raw Materials</strong></p><p>
</p><p>Geopolitical and climatic factors create persistent challenges in maintaining <strong>consistent supply</strong> of high-quality citrus aurantium raw material. Brazil and China, which collectively produce over 75% of global citrus aurantium fruits, have experienced fluctuating yields due to extreme weather events. The 2023-2024 growing season saw a 12% reduction in optimal harvests, leading to price increases of up to 22% for premium-grade extracts. These supply constraints particularly impact small and medium manufacturers who lack long-term contracts with suppliers. While forward contracts have stabilized some supply chains, the inherent seasonality of citrus crops continues to present formulation and pricing challenges across the industry.</p><p>
<strong>MARKET OPPORTUNITIES</strong></p><p>
</p><p style="text-align:center"><strong>Expansion into Emerging Markets with Growing Health Consciousness</strong></p><p>
</p><p>The Asia-Pacific region represents a <strong>high-growth opportunity</strong> for citrus aurantium extracts, particularly in markets with burgeoning middle-class populations. Countries like India, Indonesia, and Vietnam are experiencing rapid growth in preventive healthcare spending, projected to increase by 9.2% annually through 2032. Local formulators are increasingly incorporating synephrine into traditional herbal matrices, creating hybrid products that blend Western supplement science with Eastern medicine principles. Regulatory environments in these markets remain relatively favorable, with 72% of APAC nations permitting synephrine in dietary supplements at levels comparable to international standards. Strategic partnerships with local distributors and manufacturers could unlock this potential.</p><p>
</p><p style="text-align:center"><strong>Innovation in Delivery Formats and Synergistic Formulations</strong></p><p>
</p><p>Technological advancements enable novel <strong>delivery systems</strong> that enhance synephrine's efficacy and consumer acceptance. Microencapsulation techniques developed in 2024 have improved the stability and bioavailability of citrus extracts in ready-to-drink beverages by 38%. Furthermore, research into synergistic ingredient combinations has identified several promising stacks, including synephrine with hesperidin and naringin, which demonstrate enhanced thermogenic effects in clinical models. The development of time-release formulations and flavor-masking technologies addresses previous limitations regarding taste and duration of action, opening new applications in functional foods and sustained-energy products.</p><p>
</p><p style="text-align:center"><strong>Premiumization Trend in Sports Nutrition Sector</strong></p><p>
</p><p>The <strong>sports nutrition industry's</strong> shift toward premium, clinically-supported ingredients creates favorable conditions for high-quality citrus aurantium extracts. Professional and amateur athletes increasingly seek natural performance enhancers, with the global sports nutrition market projected to reach $81 billion by 2032. Synephrine's dual-action benefits for both fat metabolism and energy production position it as an attractive ingredient for next-generation performance formulations. Brand differentiation through standardized extract potencies and enhanced purity specifications (â‰¥98% synephrine alkaloids) commands premium pricing, with clinical-grade extracts trading at 25-30% premiums over commodity-grade material.</p><p>
<strong>MARKET CHALLENGES</strong></p><p>
</p><p style="text-align:center"><strong>Inconsistent Quality Standards Across Supply Chains</strong></p><p>
</p><p>The market contends with significant <strong>quality variability</strong> in citrus aurantium raw materials and extracts. Analytical testing of commercial products in 2024 revealed that 28% failed to meet label claims for synephrine content, with variations ranging from 15-140% of declared values. This inconsistency stems from multiple factors including differences in citrus cultivars, extraction methodologies, and intentional adulteration. The lack of universally accepted testing protocols compounds the problem, with HPLC methods varying significantly between laboratories. These quality control challenges erode consumer confidence and complicate regulatory compliance, particularly in markets with strict supplement oversight.</p><p>
</p><p style="text-align:center"><strong>Consumer Misperceptions About Safety Profile</strong></p><p>
</p><p>Persistent <strong>misinformation</strong> about synephrine's safety continues to impact market growth. Despite numerous clinical studies demonstrating the safety of properly dosed citrus aurantium extracts, consumer surveys indicate that 42% of potential buyers express concerns about cardiovascular risks. These perceptions stem partly from historical associations with ephedra and exaggerated media reports about isolated adverse events. The supplement industry faces an ongoing educational challenge to differentiate synephrine from more potent stimulants while promoting responsible usage guidelines. Compounding this issue, social media platforms have amplified anecdotal reports of side effects, making claims management an increasingly important aspect of marketing strategies.</p><p>
</p><p style="text-align:center"><strong>Price Sensitivity in Key Consumer Segments</strong></p><p>
</p><p>Economic pressures have increased <strong>price consciousness</strong> among core demographic groups for weight management products. Market data shows that 61% of supplement consumers now prioritize cost over premium ingredients, particularly in markets experiencing inflationary pressures. This trend disadvantages higher-priced citrus aurantium formulations compared to synthetic alternatives and lower-cost botanicals. Private label brands have capitalized on this shift, offering synephrine-containing products at 25-40% discounts to branded equivalents. While premiumization opportunities exist in specialized segments, mainstream market penetration requires cost optimization throughout the supply chain to remain competitive against alternative thermogenic ingredients.</p><p>
</p><p>
<strong>Segment Analysis:</strong></p><p>
<strong>By Type</strong></p><p>
</p><p><strong>Food Grade Segment Leads Due to Rising Demand in Nutraceutical Applications</strong></p><p>
</p><p>The market is segmented based on type into:</p><p>
</p><p>Food Grade</p><p>Widely used in dietary supplements and functional foods</p><p>Medical Grade</p><p>Pharmaceutical formulations and weight management products</p><p>Industry Grade</p><p>Used in cosmetic and personal care products</p><p>
<strong>By Application</strong></p><p>
</p><p><strong>Food &amp; Supplement Segment Dominates with Increasing Consumer Health Awareness</strong></p><p>
</p><p>The market is segmented based on application into:</p><p>
</p><p>Food &amp; Supplement</p><p>Energy boosters and weight management products</p><p>Medicine</p><p>Traditional medicine formulations and modern pharmaceuticals</p><p>Cosmetics</p><p>Anti-aging and skin care formulations</p><p>Others</p><p>Including research applications and industrial uses</p><p>
<strong>By End User</strong></p><p>
</p><p><strong>Nutraceutical Industry Accounts for Major Market Share Due to Rising Health Trends</strong></p><p>
</p><p>The market is segmented based on end user into:</p><p>
</p><p>Nutraceutical Companies</p><p>Pharmaceutical Manufacturers</p><p>Cosmetic Producers</p><p>Research Institutions</p><p>
</p><p>
<strong>COMPETITIVE LANDSCAPE</strong></p><p>
<strong>Key Industry Players</strong></p><p>
</p><p style="text-align:center"><strong>Established Brands Dominate While New Entrants Focus on Niche Segments</strong></p><p>
</p><p>The global Citrus Aurantium Extract Synephrine market features a mix of established manufacturers and emerging specialty suppliers. <strong>Hangzhou Greensky Biological Tech</strong> leads the market with an estimated 18% revenue share in 2024, owing to its vertically integrated supply chain and strong presence in China's botanical extract market. The company recently expanded its production capacity by 30% to meet growing European demand for weight management supplements.</p><p>
</p><p><strong>Sigma-Aldrich (Merck KGaA)</strong> maintains a strong position in pharmaceutical-grade synephrine extracts, leveraging its global distribution network and research partnerships. The company invested â‚¬15 million in 2023 to upgrade its extraction facilities, signaling commitment to this growing segment. Meanwhile, <strong>Nutra Green Biotechnology</strong> has been gaining traction through proprietary extraction methods that yield higher purity levels, currently holding 12% of the medical-grade market.</p><p>
</p><p>Several mid-sized players are making strategic moves to capture specific applications. <strong>Wagott International</strong> specializes in sports nutrition formulations, while <strong>Hawk-bio</strong> has carved a niche in cosmetic applications, where synephrine is increasingly used for its skin-toning properties. These targeted approaches allow smaller companies to compete despite the dominance of larger players.</p><p>
<strong>List of Key Citrus Aurantium Extract Synephrine Companies Profiled</strong></p><p>
</p><p>Hangzhou Greensky Biological Tech (China)</p><p>Sigma-Aldrich (Merck KGaA) (Germany)</p><p>Wagott International (U.S.)</p><p>Nutra Green Biotechnology (China)</p><p>Hawk-bio (China)</p><p>OSST Chemical (China)</p><p>Xi'an Natural Field Bio-Technique (China)</p><p>Shanxi Yongyuan Biotechnology (China)</p><p>NutraClick (U.S.)</p><p>
</p><p>
<strong>CITRUS AURANTIUM EXTRACT SYNEHRINE MARKET TRENDS</strong></p><p>
<strong>Growing Demand for Natural Weight Management Solutions Drives Market Expansion</strong></p><p>
</p><p>The global market for Citrus Aurantium Extract Synephrine is experiencing robust growth, primarily fueled by increasing consumer preference for natural weight management supplements. Derived from bitter orange, synephrine has gained prominence as a thermogenic agent in fat-burning formulations, with the global supplements market projected to exceed $300 million in annual revenue by 2025. While synthetic alternatives exist, manufacturers are pivoting toward plant-derived actives to meet clean-label demands. Regulatory bodies in North America and Europe maintain strict oversight, but growing clinical evidence supporting synephrine's efficacy at standard doses continues to bolster product development.</p><p>
<strong>Other Trends</strong></p><p>
</p><p><strong>Pharmaceutical Applications Gain Traction</strong></p><p>
</p><p>Beyond dietary supplements, pharmaceutical-grade Citrus Aurantium Extract is finding applications in cardiovascular and metabolic health formulations. Recent studies indicate its potential as an adjunct therapy for mild hypertension, with research expenditure in this segment growing at 12% CAGR since 2020. However, formulation challenges regarding optimal bioavailability remain an industry focus. Leading manufacturers are investing heavily in nanoemulsion technologies to enhance absorption rates while minimizing gastrointestinal side effects.</p><p>
<strong>Asia-Pacific Emerges as Key Production and Consumption Hub</strong></p><p>
</p><p>China's dominance in raw material supply continues unabated, accounting for over 65% of global Citrus Aurantium cultivation. Meanwhile, India and Southeast Asian markets are witnessing explosive growth in domestic consumption, with supplement sales growing 18% year-over-year as disposable incomes rise. Regulatory frameworks in these regions remain less restrictive than Western markets, enabling faster product launches. However, quality control issues persist, prompting multinational brands to establish stringent supplier verification programs. The forecast period through 2032 will likely see increased vertical integration as processors secure direct access to premium-grade raw materials.</p><p>
</p><p>
<strong>Regional Analysis: Citrus Aurantium Extract Synephrine Market</strong></p><p>
</p><p><strong>North America</strong></p><p>
The North American market for <strong>Citrus Aurantium Extract Synephrine</strong> is primarily driven by its widespread use in dietary supplements and weight management products. The region benefits from strict FDA regulations ensuring product safety, though recent controversies around synephrine's stimulant effects have led to increased scrutiny. The U.S. dominates consumption, with the sports nutrition sector accounting for over 40% of demand as of 2024. However, regulatory uncertainty in Canada regarding alkaloid content limits presents challenges for market expansion. The growing preference for natural thermogenic ingredients in functional foods continues to support steady growth, with projections indicating a <strong>5-7% CAGR through 2032</strong>.</p><p>
</p><p><strong>Europe</strong></p><p>
Europe maintains a complex regulatory landscape for synephrine products, with EFSA maintaining cautious stance on its safety profile. Despite this, Germany and the UK emerge as key markets, where <strong>medical-grade extracts</strong> find applications in pharmaceuticals for metabolic support. The <strong>EU Novel Food Regulation</strong> poses hurdles for new product launches, compelling manufacturers to invest heavily in clinical research. Traditional medicine applications in Southern Europe and growing demand for natural energy boosters in the Nordic countries present niche opportunities. Market growth remains moderate (3-4% annually) due to regulatory constraints, though Brexit has simplified UK market access for some suppliers.</p><p>
</p><p><strong>Asia-Pacific</strong></p><p>
As the global production hub, Asia-Pacific accounts for <strong>over 60% of Citrus Aurantium cultivation and extraction capacity</strong>, with China leading both supply and domestic consumption. The region benefits from cost-efficient production and established traditional medicine applications. India shows remarkable growth potential, with Ayurvedic formulations incorporating synephrine gaining popularity. While Japan's stringent health supplement regulations limit market penetration, Southeast Asian markets exhibit <strong>8-10% annual growth</strong> fueled by rising disposable incomes and weight management trends. The lack of standardized regulations across the region creates both opportunities for market entry and challenges regarding product consistency.</p><p>
</p><p><strong>South America</strong></p><p>
Brazil dominates the regional market, where Citrus Aurantium (known locally as laranja-azeda) has traditional uses in folk medicine. The extract finds increasing application in sports nutrition products, though economic instability affects premium supplement sales. Regulatory frameworks vary significantly - Argentina maintains strict controls while Colombia shows more leniency toward natural stimulants. The Andean region presents growth potential through traditional medicine channels, though lack of clinical validation hampers expansion into mainstream healthcare applications. Market growth remains modest at <strong>4-5% annually</strong>, closely tied to macroeconomic conditions.</p><p>
</p><p><strong>Middle East &amp; Africa</strong></p><p>
The MEA market shows polarized development - Gulf Cooperation Council (GCC) countries demonstrate strong demand for imported weight management products containing synephrine, while African markets rely primarily on traditional preparations. South Africa serves as the most developed market, with increasing interest in sports nutrition. Regulatory environments remain underdeveloped across most African nations, creating challenges for quality control. The region shows potential for <strong>6-8% growth through 2032</strong>, particularly through halal-certified product lines in Muslim-majority countries, though political instability and limited healthcare infrastructure in some areas constrain faster expansion.</p><p>
</p><p>

</p><p></p><p><strong>Key Report Takeaways</strong></p><p></p><p>
</p><p>
</p><p>
</p><p>
</p><p>
</p><p>
</p><p>
</p><p>

<strong>Report Scope</strong></p><p>
</p><p>This report presents a comprehensive analysis of the global and regional markets for Citrus Aurantium Extract Synephrine, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:</p><p>
</p><p><strong>Sales, sales volume, and revenue forecasts</strong></p><p><strong>Detailed segmentation by type and application</strong></p><p>
</p><p>In addition, the report offers in-depth profiles of key industry players, including:</p><p>
</p><p>Company profiles</p><p>Product specifications</p><p>Production capacity and sales</p><p>Revenue, pricing, gross margins</p><p>Sales performance</p><p>
</p><p>It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.</p><p>
</p><p>As part of this research, we surveyed Citrus Aurantium Extract Synephrine companies and industry experts. The survey covered various aspects, including:</p><p>
</p><p>Revenue and demand trends</p><p>Product types and recent developments</p><p>Strategic plans and market drivers</p><p>Industry challenges, obstacles, and potential risks</p><p>
<strong>FREQUENTLY ASKED QUESTIONS:</strong></p><p>
<strong>What is the current market size of Global Citrus Aurantium Extract Synephrine Market?</strong></p><p>
</p><p><strong>-&gt;</strong> Global Citrus Aurantium Extract Synephrine market was valued at <strong>USD 412.5 million in 2024</strong> and is expected to reach <strong>USD 752.8 million by 2032</strong>.</p><p>
<strong>Which key companies operate in Global Citrus Aurantium Extract Synephrine Market?</strong></p><p>
</p><p><strong>-&gt; Key players</strong> include <strong>Hangzhou Greensky Biological Tech, Sigma-Aldrich, Wagott, Nutra Green Biotechnology, Hawk-bio, and OSST</strong>, among others.</p><p>
<strong>What are the key growth drivers?</strong></p><p>
</p><p>-&gt; Key growth drivers include <strong>rising demand for natural weight management solutions, increasing sports nutrition adoption, and growth in herbal supplement industry</strong>.</p><p>
<strong>Which region dominates the market?</strong></p><p>
</p><p><strong>-&gt; Asia-Pacific</strong> is the largest production region, while <strong>North America</strong> leads in consumption.</p><p>
<strong>What are the emerging trends?</strong></p><p>
</p><p>-&gt; Emerging trends include <strong>clinical validation of safety profiles, development of standardized extracts, and expansion into pharmaceutical applications</strong>.</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/168758/global-citrus-aurantium-extract-synephrine-market">
            https://www.24chemicalresearch.com/reports/168758/global-citrus-aurantium-extract-synephrine-market</a></b></div><br>
            <b>Table of Content:</b><p>Chapter One Introduction of Citrus Aurantium Extract Synephrine Industry<br />
1.1 Brief Introduction of Citrus Aurantium Extract Synephrine<br />
1.2 Development of Citrus Aurantium Extract Synephrine Industry<br />
1.3 Status of Citrus Aurantium Extract Synephrine Industry<br />
<br />
Chapter Two Manufacturing Technology of Citrus Aurantium Extract Synephrine<br />
2.1 Development of Citrus Aurantium Extract Synephrine Manufacturing Technology<br />
2.2 Analysis of Citrus Aurantium Extract Synephrine Manufacturing Technology<br />
2.3 Trends of Citrus Aurantium Extract Synephrine Manufacturing Technology<br />
<br />
Chapter Three Analysis of Global Key Manufacturers<br />
3.1 Hangzhou Greensky Biological Tech<br />
3.1.1 Company Profile<br />
3.1.2 Product Information<br />
3.1.3 2017-2022 Production Information<br />
3.1.4 Contact Information<br />
3.2 Sigma-Aldrich<br />
3.2.1 Company Profile<br />
3.2.2 Product Information<br />
3.2.3 2017-2022 Production Information<br />
3.2.4 Contact Information<br />
3.3 Wagott<br />
3.2.1 Company Profile<br />
3.3.2 Product Information<br />
3.3.3 2017-2022 Production Information<br />
3.3.4 Contact Information<br />
3.4 Nutra Green Biotechnology<br />
3.4.1 Company Profile<br />
3.4.2 Product Information<br />
3.4.3 2017-2022 Production Information<br />
3.4.4 Contact Information<br />
3.5 Hawk-bio<br />
3.5.1 Company Profile<br />
3.5.2 Product Information<br />
3.5.3 2017-2022 Production Information<br />
3.5.4 Contact Information<br />
3.6 OSST<br />
3.6.1 Company Profile<br />
3.6.2 Product Information<br />
3.5.3 2017-2022 Production Information<br />
3.6.4 Contact Information<br />
3.7 Shanghai Passiono International<br />
3.7.1 Company Profile<br />
3.7.2 Product Information<br />
</p>

<div><b>Get the Complete Report & TOC @ 
            <a href="https://www.24chemicalresearch.com/reports/168758/global-citrus-aurantium-extract-synephrine-market">
            https://www.24chemicalresearch.com/reports/168758/global-citrus-aurantium-extract-synephrine-market</a></b></div><br>

<b>CONTACT US:</b><br>
            203A, City Vista, Fountain Road, Kharadi, Pune, India - 411014<br>
            International: +1(332) 2424 294<br>
            Asia: +91 9169162030 <br><br>
            Follow Us On LinkedIn: <a href="https://www.linkedin.com/company/24chemicalresearch/">24ChemicalResearch LinkedIn</a>